logo

For the Inventor, By the Inventor

Seoul, South Korea

Ji In Jung

This inventor holds 1 USPTO granted patent. Top assignee: Intron Blotechnology, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji In Jung. Retrieved from https://idiyas.com/inventor/ji-in-jung-wcjzm2d4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 1 
 
Intron Blotechnology, Inc.
 patent

Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents
1. 11844818 - bacteriophage Aer-HYP-3 and use thereof for inhibiting growth ofbacteria (2023-12-19),

Title: Ji In Jung: Innovator in Bacteriophage Research

Introduction

Ji In Jung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, specifically through his work on bacteriophages, which are viruses that infect and kill bacteria. His research has important implications for treating bacterial infections and advancing medical science.

Latest Patents

Ji In Jung is credited with a patent for the Myoviridae bacteriophage Aer-HYP-3 (Accession number: KCTC 13479BP). This bacteriophage demonstrates a remarkable ability to eliminate bacteria, making it a powerful tool for preventing and treating diseases caused by bacterial infections. The patent details the genome of this bacteriophage, represented by SEQ ID NO: 1, and describes a methodology for using a composition containing Aer-HYP-3 as an active ingredient in therapeutic applications.

Career Highlights

Ji In Jung is affiliated with Intron Biotechnology, Inc., where he continues his innovative research and development efforts. His expertise in bacteriophage technology positions him at the forefront of efforts to tackle bacterial resistance and improve therapeutic strategies. The impact of his work is particularly relevant in today’s context of rising antibiotic resistance.

Collaborations

Throughout his career, Ji In Jung has collaborated with esteemed colleagues, including Seong Jun Yoon and Soo Youn Jun. These partnerships are vital for the advancement of research and development in biotechnology, allowing for a multidisciplinary approach to solving complex health problems related to bacterial infections.

Conclusion

In summary, Ji In Jung stands out as an influential inventor and researcher, particularly in the area of bacteriophage technology. His patent contributes to ongoing efforts to combat bacterial diseases and highlights the potential of innovative solutions in biotechnology. As his work continues to develop, it promises to play a crucial role in improving public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…